Luisa Imberti Selected Research

Luisa Imberti Research Topics

Disease

18	COVID-19 08/2022 - 01/2020
16	Multiple Sclerosis 10/2020 - 09/2007
7	Infections 10/2020 - 03/2002
6	Progressive Multifocal Leukoencephalopathy 01/2020 - 09/2013
6	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018 - 04/2004
5	Pneumonia (Pneumonitis) 10/2021 - 09/2020
5	HIV Infections (HIV Infection) 01/2020 - 09/2005
4	Virus Diseases (Viral Diseases) 08/2022 - 06/2011
4	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2018 - 11/2005
4	Neoplasms (Cancer) 09/2012 - 01/2009
3	Relapsing-Remitting Multiple Sclerosis 01/2020 - 02/2014
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2018 - 06/2011
3	Lymphoma (Lymphomas) 12/2016 - 09/2005
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2016 - 10/2002
3	Melanoma (Melanoma, Malignant) 09/2010 - 01/2009
2	Disease Progression 01/2021 - 07/2017
2	Immune Reconstitution Inflammatory Syndrome 01/2019 - 07/2017
2	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 09/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2016 - 09/2005
2	Hepatitis 04/2007 - 01/2005
1	Convalescence 08/2022
1	COVID-19 related pediatric multisystem inflammatory disease 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Gastritis 01/2022
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Thymoma (Thymic Carcinoma) 11/2021
1	Sclerosing Cholangitis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Asymptomatic Infections 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2020
1	Persistent Infection 01/2020
1	Multiple Myeloma 05/2019
1	Seizures (Absence Seizure) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018
1	Opportunistic Infections (Opportunistic Infection) 10/2017
1	Residual Neoplasm 02/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016

Drug/Important Bio-Agent (IBA)

10	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2020 - 10/2002
8	AutoantibodiesIBA 08/2022 - 10/2020
8	AntibodiesIBA 01/2022 - 09/2007
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
7	Natalizumab (Tysabri)FDA Link 01/2020 - 01/2012
6	InterferonsIBA 08/2022 - 09/2010
5	AntigensIBA 01/2022 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2011
5	Peptides (Polypeptides)IBA 09/2020 - 01/2009
5	Interferon-betaIBA 01/2015 - 06/2008
5	Messenger RNA (mRNA)IBA 01/2014 - 03/2008
4	VaccinesIBA 11/2021 - 01/2009
4	Interferon Type IIBA 10/2021 - 03/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2007
3	CytokinesIBA 02/2018 - 03/2011
3	Adenosine DeaminaseIBA 01/2018 - 11/2005
3	Staphylococcal Protein A (Protein A)IBA 01/2014 - 11/2008
3	MART-1 AntigenIBA 09/2010 - 01/2009
2	Immunoglobulin G (IgG)IBA 08/2022 - 10/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2003
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2003
2	Chemokine CCL5IBA 01/2020 - 03/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2018 - 01/2015
2	Monoclonal AntibodiesIBA 10/2017 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 03/2011
2	pegademase bovine (pegADA)FDA Link 12/2010 - 11/2005
2	Dacarbazine (DIC)FDA LinkGeneric 09/2010 - 01/2009
2	Cancer VaccinesIBA 03/2009 - 01/2009
1	Adenosine Triphosphatases (ATPase)IBA 01/2022
1	AutoantigensIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	mRNA VaccinesIBA 11/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	InterleukinsIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Toll-Like Receptor 3IBA 10/2020
1	Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA 10/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2020
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020
1	Therapeutic UsesIBA 01/2020
1	factor AIBA 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 05/2019
1	Alemtuzumab (Campath)FDA Link 01/2019
1	thymoglobulin FDA Link 11/2018
1	nitazoxanide (NTZ)FDA Link 07/2017
1	Maraviroc FDA Link 07/2017
1	Immunoglobulin M (IgM)IBA 01/2016
1	EnzymesIBA 10/2015

Therapy/Procedure

20	Therapeutics 01/2022 - 09/2005
6	Transplantation 10/2015 - 04/2004
5	Stem Cell Transplantation 11/2018 - 10/2002
4	Hematopoietic Stem Cell Transplantation 01/2014 - 09/2005
3	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 01/2003
3	Drug Therapy (Chemotherapy) 12/2016 - 09/2005
1	Phototherapy (Light Therapy) 02/2018
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2016